Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson Contact Lenses / Other (ACUVUE) by Quarter
Contact Lenses / Other (ACUVUE) — Worldwide sales ($M) ($M)
Johnson & Johnson Contact Lenses / Other (ACUVUE): $1,053M in Q3 2026, up 3.4% from a year earlier. That is the highest of the 40 quarters on record here.
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-10-21) ↗
Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up contact Lenses / Other (ACUVUE)
- Contact Lenses / Other (ACUVUE) — U.S. sales ($M)465 · Q3 2026
- Contact Lenses / Other (ACUVUE) — International sales ($M)588 · Q3 2026
- Contact Lenses / Other (ACUVUE) — Worldwide reported growth YoY (%)3.5% · Q3 2026
- Contact Lenses / Other (ACUVUE) — Worldwide operational (constant-currency) growth YoY (%)4.3% · Q3 2026
Cite this data
StockData. (2026). Johnson & Johnson Contact Lenses / Other (ACUVUE) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-vis-contact-lenses
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.